Next Article in Journal
Differences in Drug-Susceptibility Patterns between Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium chimaera Clinical Isolates: Prospective 8.5-Year Analysis by Three Laboratories
Next Article in Special Issue
Relationship between Phenotypic and Genotypic Resistance of Subgingival Biofilm Samples in Patients with Periodontitis
Previous Article in Journal
KPC-Producing Enterobacterales from Douro River, Portugal—Persistent Environmental Contamination by Putative Healthcare Settings
Previous Article in Special Issue
Conventional and Real-Time PCR Targeting blaOXA Genes as Reliable Methods for a Rapid Detection of Carbapenem-Resistant Acinetobacter baumannii Clinical Strains
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria

by
Lena Josephine Wolf
* and
Catalina-Suzana Stingu
Institute for Medical Microbiology and Virology, University Hospital of Leipzig, 04103 Leipzig, Germany
*
Author to whom correspondence should be addressed.
Antibiotics 2023, 12(1), 63; https://doi.org/10.3390/antibiotics12010063
Submission received: 28 November 2022 / Revised: 23 December 2022 / Accepted: 27 December 2022 / Published: 29 December 2022

Abstract

Anaerobes play an important role in clinically relevant infections and resistance is increasing worldwide. We tested 120 rare anaerobic isolates belonging to 16 genera for antimicrobial resistance using the agar dilution method and compared those results to the time-saving E-test method. The susceptibility data for 12 antimicrobial substances (benzylpenicillin, ampicillin/sulbactam, piperacillin/tazobactam, imipenem, meropenem, cefoxitin, metronidazole, moxifloxacin, clindamycin, doxycycline, tigecycline, eravacycline) were collected. Susceptibility testing showed low resistance to β-lactam/β-lactamase inhibitor combinations and no resistance to carbapenems and tigecycline. We observed moderate to high rates of resistance to moxifloxacin and clindamycin which differed depending on the methodology used. The essential and categorical agreement was over 90% for ampicillin/sulbactam, meropenem, moxifloxacin, and tigecycline. For metronidazole and clindamycin, the essential agreement was below 90% but the categorical agreement was near or above 90%. Penicillin presented with the lowest categorical agreement of 86.7% and a very high very major error rate of 13.3%. The resistance rates reported in this study are concerning and show the importance of routine susceptibility testing. Further investigations are necessary to determine the reason for high error rates and how to improve susceptibility testing of fastidious anaerobes.
Keywords: antimicrobial susceptibility; anaerobic bacteria; E-test; agar dilution method antimicrobial susceptibility; anaerobic bacteria; E-test; agar dilution method

Share and Cite

MDPI and ACS Style

Wolf, L.J.; Stingu, C.-S. Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria. Antibiotics 2023, 12, 63. https://doi.org/10.3390/antibiotics12010063

AMA Style

Wolf LJ, Stingu C-S. Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria. Antibiotics. 2023; 12(1):63. https://doi.org/10.3390/antibiotics12010063

Chicago/Turabian Style

Wolf, Lena Josephine, and Catalina-Suzana Stingu. 2023. "Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria" Antibiotics 12, no. 1: 63. https://doi.org/10.3390/antibiotics12010063

APA Style

Wolf, L. J., & Stingu, C.-S. (2023). Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria. Antibiotics, 12(1), 63. https://doi.org/10.3390/antibiotics12010063

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop